NCT02500498View on ClinicalTrials.gov

Safety Profile of Nulojix in Home Infusion Settings

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Nulojix

Sponsors

Collaborators (1)

BiologicTx, LLC
All Listed Sponsors
collaborator

BiologicTx, LLC

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT02500498 - Safety Profile of Nulojix in Home Infusion Settings | Biotech Hunter | Biotech Hunter